amb041

Andrea Barsevick, PhD

Contact Dr. Barsevick

834 Chestnut Street
The Franklin Building, Suite 314
Philadelphia, PA 19107

(215) 503-4623
(215) 503-9506 fax

Most Recent Peer-reviewed Publications

  1. Identifying the subtypes of cancer-related fatigue: results from the population-based PROFILES registry
  2. Advancing symptom science through symptom cluster research: Expert panel proceedings and recommendations
  3. Post-treatment problems of African American breast cancer survivors
  4. Symptom Clusters
  5. Defining the Symptom Cluster: How Far Have We Come?
  6. Validity and reliability of the taiwanese version of the general fatigue scale in cancer patients
  7. Management of cancer-related fatigue during chemotherapy through telephone motivational interviewing: Modeling and randomized exploratory trial
  8. Subgroups of cancer patients with unique pain and fatigue experiences during chemotherapy
  9. Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update
  10. Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy
  11. Comparison of groups with different patterns of symptom cluster intensity across the Breast Cancer Treatment Trajectory
  12. Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: An update
  13. Recommendations for high-priority research on cancer-related fatigue in children and adults
  14. The personal patient profile-prostate decision support for men with localized prostate cancer: A multi-center randomized trial
  15. Preparing individuals to communicate genetic test results to their relatives: Report of a randomized control trial
  16. Cancer-related fatigue and its impact on functioning
  17. Predictors of depression in breast cancer patients treated with radiation: Role of prior chemotherapy and nuclear factor kappa B
  18. Cancer symptom cluster research: New perspectives and tools
  19. Common biological pathways underlying the psychoneurological symptom cluster in cancer patients
  20. Clinical subgroups of a psychoneurologic symptom cluster in women receiving treatment for breast cancer: A secondary analysis